Skinbac
Probiotical - Linkedin Probiotical - E-mail

LS03 + BR03™ + LC03 (BIFIACNEL)

Blend
Blend
Home / Our Products / Strains and Blends
← Back to research page
On this page

Dermatology

Acne

Functionality

Inhibits C. acnes and its induction of IL-8

Inhibits proinflammatory IL-8

Anti-inflammatory activity

Dosage / Clinical Study

1) LS03 1 billion CFU/AFU+ BR03 0.5 billion CFU/AFU + LC03 0.5 billion CFU/AFU

Available Formats

Blend

Finished dosage form

Scientific Support
Clinical studies

1) Rinaldi F. et al. Facial Acne: A Randomized, Double-Blind, Placebo-Controlled Study on the Clinical Efficacy of a Symbiotic Dietary Supplement. Dermatol Ther (Heidelb). 2022 Feb;12(2):577-589. doi: 10.1007/s13555-021-00664-z.

In vitro studies

a) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216.  DOI: 10.35248/2329-8901.20.8.216

b) Nicola S. et al. Interaction between probiotics and human immune cells: the prospective anti-inflammatory activity of Bifidobacterium breve BR03. AgroFOOD, 2010; 21(2):S44-47

c) Amoruso A. et al. (2019) A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus plantarum LP01 (LMG P-21021). J Prob Health. 7:214. Doi: 10.35248/2329-8901.19.7.214

Associations